Molecular Oncology
and Cell Death
Arbeitsgruppe Prof. Dr. Philipp Jost
Research Interests
The aim of our research group “Molecular Oncology” is to elucidate the basic principles restricting cell death in cancer and their relevance for clinical translation.
Our research group studies the regulation of cell death in healthy and malignant cells. The focus of our work is the understanding of cell death mechanisms and their regulation in tumor cell initiation, tumor maintenance and resistance mechanisms. As model systems we employ genetic deletion or pharmacologic inhibition of individual cell death regulating proteins in various murine tumor models. In addition, we also employ spatiotemporal deletion of individual cell death regulating proteins for characterization of their role in tumor initiation and maintenance. Moreover, we place a specific focus on the rapid translation of murine data into patients.
Horak P, Heining C, Kreutzfeldt S. Hutter B, Mock A, Hullein J, Frohlich M, Uhrig S, Jahn A, Rump A, Gieldon L, Mohrmann L, Hanf D, Teleanu V, Heilig CE, Lipka DB, Allgauer M, Ruhnke L, Lassmann A, Endris V, Neumann O, Penzel R, Beck K, Richter D, Winter U, Wolf S, Pfutze K, Georg C, Meissburger B, Buchhalter I, Augustin M, Aulitzky WE, Hohenberger P, Kroiss M, Schrimacher P, Schlenk RF, Keilholz U, Klauschen F, Folprecht G, Bauer S, Siveke JT, Brandts CH, Kindler T, Boerries M, Illert AL, von Bubnoff N, Jost PJ, Spiekermann K, Bitzer M, Schulze-Osthoff K, von Kalle C, Klink B, Brors B, Stenzinger A, Schrock E, Hubschmann D, Weichert W, Glimm H, Frohling S., Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions with Patients with rare cancers. Cancer Discov. 2021 PMID: 34112699
Wang X, Ros U, Agrawal D, Keller EC, Slotta-Huspenina J, Dill V, Shen B, Shi R, Herold T, Belka C, Misra R, Bassermann F, Garcia-Saez AJ, Jost PJ. MLKL promotes cellular differentiation in myeloid leukemia by facilitating the relase of G-CSF. Cell Death Differ. 2021 Jun 2. PMID: 34079078
Jayavelu AK, Schnöder TM, Perner F. Herzog C, Meiler A, Krrishnamoorthy G, Huber N, Mohr J, Edelmann-Stephan B, Austin R, Brandt S, Palandri F, Schröder N, Isermann B, Edlich F, Sinha AU, Ungelenk M, Hübner CA, Zeiser R, Rahmig S, Waskow C. Coldham I, Ernst T, Hochhaus A, Jilg S, Jost PJ, Mullally A, Bullingewr L, Mertens PR, Lane SW, Mann M, Heidel FH. Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms. Nature. 2020, 588(7836):157-163. PMID:33239784
Munkhbaatar E, Dietzen M, Agrawal D, Anton D, Jesinghaus M, Boxberg M, Pfarr N, Bidola P, Uhrig S, Höckendorf U, Meinhardt AL, Wahida A, Heid I, Braren R, Mishra R, Warth A, Muley T, Poh PSP, Wang X, Fröhling S, Steiger K, Slotta-Huspenina J, van Griensven M, Pfeiffer F, Lange S, Rad R, Spella M. Stathopoulos GT, Ruland J, Bassermann F, Weichert W, Strasser A, Branca C, Heikenwalder M, Swanton C, McGranahan N, Jost PJ. MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically. Nat Commun. 2020 11(1):4527. PMID: 32913197
Jost PJ, Vucic D. Regulation of Cell Death and Immunity by XIAP. Cold Spring Harb Perspect Biol. 2020. PMID: 31843992
Müller N, Fischer JC, Yabal M, Haas T, Poeck H, Jost PJ.
XIAP deficiency in hematopoietic recipient cells drives donor T-cell activation and GvHD in mice.
Eur J Immunol, 2018.
Jost PJ, Höckendorf U.
Necroinflammation emerges as a key regulator of hematopoiesis in health and disease.
Cell Death and Differentiation, 2018.
Lawlor KE*, Feltham R*, Yabal M*, Conos SA, Chen KW, Ziehe S, Grass C, Zhan Y, Nguyen T, Hall C, Vince AJ, Chatfield SM, D'Silva DB, Pang KC, Schroder K, Silke J, Vaux DL, Jost PJ*, Vince JE*.
XIAP Loss Triggers RIPK3- and Caspase-8-Driven IL-1beta Activation and Cell Death as a Consequence of TLR-MyD88-Induced cIAP1-TRAF2 Degradation.
Cell Rep, 2017.
Höckendorf U*, Yabal M*, Herold T, Munkhbaatar E, Rott S, Jilg S, Kauschinger J, Magnani G, Reisinger F, Heuser M, Kreipe H, Sotlar K, Engleitner T, Rad R, Weichert W, Peschel C, Ruland J, Heikenwalder H, Spiekermann K, Slotta-Huspenina J, Groß O and Jost PJ.
RIPK3 restricts myeloid leukemogenesis by promoting cell death and differentiation of leukemia initiating cells.
Cancer Cell, 2016.
Spinner S, Crispatzu G, Yi JH, Munkhbaatar E, Mayer P, Höckendorf U, Müller N, Li Z, Schader T, Bendz H, Hartmann S, Yabal M, Pechloff K, Heikenwalder M, Kelly GL, Strasser A, Peschel C, Hansmann ML, Ruland J, Keller U, Newrzela S, Herling M, Jost PJ.
Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance.
Leukemia, 2016.
Jilg S, Reidel V, Müller-Thomas C, König J, Schauwecker J, Höckendorf U, Huberle C, Gorka O, Schmidt B, Burgkart R, Ruland J, Kolb HJ, Peschel C, Oostendorp RA, Götze KS, Jost PJ.
Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients.
Leukemia, 2016.
Yabal M, Müller N, Adler H, Knies N, Groß CJ, Damgaard RB, Kanegane H, Ringelhan M, Kaufmann T, Heikenwälder M, Strasser A, Groß O, Ruland J, Peschel C, Gyrd-Hansen M, Jost PJ.
XIAP Restricts TNF- and RIP3-Dependent Cell Death and Inflammasome Activation.
Cell Rep, 2014.
Damgaard RB*, Nachbur U*, Yabal M*, Wong WWL, Fiil BK, Kastirr M, Rieser E, Rickard JA, Bankovacki A, Peschel C, Ruland J, Bekker-Jensen S, Mailand N, Kaufmann T, Strasser A, Walczak H, Silke J, Jost PJ*#, Gyrd-Hansen M*#.
The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity.
Molecular Cell, 2012.
Kaufmann, T., Strasser, A., Jost PJ.
Fas Death Receptor Signalling: Roles of Bid and XIAP.
Cell Death and Differentiation, 2012.
Vikstrom I., Carotta S., Lüthje K., Peperzak V., Jost PJ., Glaser S., Busslinger M., Bouillet P., Strasser A., Nutt SL., Tarlinton DM., Mcl-1 is Essential for Germinal Center Formation and B cell Memory,
Science, 2010.
Jost, PJ., Grabow, S., Gray, D., McKenzie, MD., Nachbur, U., Huang, DCS., Bouillet, P., Thomas, HE., Borner, C., Silke, J., Strasser, A., Kaufmann, T. XIAP discriminates between type I and type II FAS-induced apoptosis.
Nature, 2009.
(*: equal contribution; #: corresponding author)
Principal Investigator
Prof. Dr. Philipp Jost
E-Mail (link sends e-mail)
Laboratory:
Center for Translational Cancer Research (TranslaTUM)
Junior Group Leader
Dr. rer. nat. Irina Ingold
E-Mail(link sends e-mail)
Lab Members (alphabetical)
Deepti Agrawal, MSc., MD
E-Mail(link sends e-mail)
Catarina Branca, PhD
(postdoc)
E-Mail(link sends e-mail)
Lars Buschhorn, cand. med.
(medical doctoral student)
E-Mail(link sends e-mail)
Marta Dechant, cand. med.
(medical doctoral student)
E-Mail(link sends e-mail)
Veronika Dill
(postdoc/resident Dep. Hematology and Oncology)
E-Mail(link sends e-mail)
Richard Hauch, cand. med.
(medical doctoral student)
E-Mail(link sends e-mail)
Ulrike Höckendorf, Dipl. hum. biol.
(postdoc)
E-Mail(link sends e-mail)
Anna-Lena Meinhardt, physician
(medical doctoral student, doctoral program in “Translational Medicine”)
E-Mail(link sends e-mail)
Timo Odinius, cand. med.
(medical doctoral student, doctoral program in “Translational Medicine”)
E-Mail(link sends e-mail)
Celina Wagner, cand. med.
(medical doctoral student)
E-Mail(link sends e-mail)
Adam Wahida, cand. med.
(medical doctoral student, PhD student)
E-Mail
Former Members
Justus König, Dr. med. sci.
(medical doctoral student, doctoral program in “Translational Medicine”)
Nicole Müller, MSc.
(PhD student)
Anne Jacob, Dipl. biol.
(research assistant)
Sabine Spinner, PhD
Monica Yabal, PhD
(postdoc)
Stephanie Ziehe, BSc.
(research assistant)

Application
Written applications including CV are welcome and should be forwarded by e-mail(link sends e-mail) to Prof. Dr. Philipp Jost.

Third party funding
SFB1335, Aberrant Immune Signals in Cancer, DFG
SFB 1371, Microbiome Signatures, DFG
FOR2036, New insights into Bcl-2 family interactions, DFG(link is external)
Deutsche Krebshilfe